{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:18:18Z","timestamp":1786994298809,"version":"build-2736575974"},"reference-count":122,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T00:00:00Z","timestamp":1654214400000},"content-version":"vor","delay-in-days":367,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT1129757"],"award-info":[{"award-number":["GNT1129757"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT1156343"],"award-info":[{"award-number":["GNT1156343"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT1181110"],"award-info":[{"award-number":["GNT1181110"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT1185387"],"award-info":[{"award-number":["GNT1185387"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001026","name":"National Breast Cancer Foundation","doi-asserted-by":"publisher","award":["IIRS-19-017"],"award-info":[{"award-number":["IIRS-19-017"]}],"id":[{"id":"10.13039\/501100001026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Cell"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.molcel.2021.04.023","type":"journal-article","created":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T10:51:36Z","timestamp":1620816696000},"page":"2278-2289","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["The Fanconi anemia ubiquitin E3 ligase complex as an anti-cancer target"],"prefix":"10.1016","volume":"81","author":[{"given":"Michael F.","family":"Sharp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohan","family":"Bythell-Douglas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Deans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne","family":"Crismani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molcel.2021.04.023_bib1","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.molcel.2010.06.026","article-title":"Preventing nonhomologous end joining suppresses DNA repair defects of Fanconi anemia","volume":"39","author":"Adamo","year":"2010","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molcel.2021.04.023_bib2","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/s41594-020-0380-1","article-title":"FANCD2-FANCI is a clamp stabilized on DNA by monoubiquitination of FANCD2 during DNA repair","volume":"27","author":"Alc\u00f3n","year":"2020","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.molcel.2021.04.023_bib3","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.molcel.2008.12.003","article-title":"Mechanistic insight into site-restricted monoubiquitination of FANCD2 by Ube2t, FANCL, and FANCI","volume":"32","author":"Alpi","year":"2008","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molcel.2021.04.023_bib4","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0167-8140(01)00474-1","article-title":"Radiosensitivity in Fanconi\u2019s anemia patients","volume":"62","author":"Alter","year":"2002","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.molcel.2021.04.023_bib5","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.chembiol.2003.09.002","article-title":"The process of structure-based drug design","volume":"10","author":"Anderson","year":"2003","journal-title":"Chem. Biol."},{"key":"10.1016\/j.molcel.2021.04.023_bib6","first-page":"4","article-title":"Fanconi anemia and its diagnosis","volume":"668","author":"Auerbach","year":"2009","journal-title":"Mutat. Res."},{"key":"10.1016\/j.molcel.2021.04.023_bib7","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1016\/j.celrep.2018.04.046","article-title":"The CST Complex Mediates End Protection at Double-Strand Breaks and Promotes PARP Inhibitor Sensitivity in BRCA1-Deficient Cells","volume":"23","author":"Barazas","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.molcel.2021.04.023_bib8","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.molcel.2018.06.030","article-title":"FANCA Promotes DNA Double-Strand Break Repair by Catalyzing Single-Strand Annealing and Strand Exchange","volume":"71","author":"Benitez","year":"2018","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molcel.2021.04.023_bib9","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1001\/archoto.2011.154","article-title":"Postoperative clinical radiosensitivity in patients with Fanconi anemia and head and neck squamous cell carcinoma","volume":"137","author":"Birkeland","year":"2011","journal-title":"Arch. Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.molcel.2021.04.023_bib10","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.ajhg.2013.04.002","article-title":"Mutations in ERCC4, encoding the DNA-repair endonuclease XPF, cause Fanconi anemia","volume":"92","author":"Bogliolo","year":"2013","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.molcel.2021.04.023_bib11","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1136\/jmedgenet-2019-106249","article-title":"Optimised molecular genetic diagnostics of Fanconi anaemia by whole exome sequencing and functional studies","volume":"57","author":"Bogliolo","year":"2020","journal-title":"J.\u00a0Med. Genet."},{"key":"10.1016\/j.molcel.2021.04.023_bib12","doi-asserted-by":"crossref","first-page":"13191","DOI":"10.1074\/jbc.RA118.002649","article-title":"Targeting TRAF6 E3 ligase activity with a small-molecule inhibitor combats autoimmunity","volume":"293","author":"Brenke","year":"2018","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.molcel.2021.04.023_bib13","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/nature03443","article-title":"Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase","volume":"434","author":"Bryant","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.molcel.2021.04.023_bib14","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/nature23481","article-title":"Mammals divert endogenous genotoxic formaldehyde into one-carbon metabolism","volume":"548","author":"Burgos-Barragan","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.molcel.2021.04.023_bib15","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1016\/j.celrep.2020.01.052","article-title":"Cooperation of the ATM and Fanconi Anemia\/BRCA Pathways in Double-Strand Break End Resection","volume":"30","author":"Cai","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.molcel.2021.04.023_bib16","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.cell.2013.06.048","article-title":"Pharmacological inactivation of Skp2 SCF ubiquitin ligase restricts cancer stem cell traits and cancer progression","volume":"154","author":"Chan","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.molcel.2021.04.023_bib17","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/nature18325","article-title":"Replication fork stability confers chemoresistance in BRCA-deficient cells","volume":"535","author":"Chaudhuri","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.molcel.2021.04.023_bib18","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1158\/1535-7163.MCT-05-0493","article-title":"Chemosensitization to cisplatin by inhibitors of the Fanconi anemia\/BRCA pathway","volume":"5","author":"Chirnomas","year":"2006","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.molcel.2021.04.023_bib19","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1158\/1535-7163.MCT-15-0945","article-title":"ATM Mutations in Cancer: Therapeutic Implications","volume":"15","author":"Choi","year":"2016","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.molcel.2021.04.023_bib20","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1042\/BCJ20160762","article-title":"Chemical approaches to targeted protein degradation through modulation of the ubiquitin-proteasome pathway","volume":"474","author":"Collins","year":"2017","journal-title":"Biochem. J."},{"key":"10.1016\/j.molcel.2021.04.023_bib21","first-page":"2148","article-title":"Small-Molecule Inhibition of UBE2T\/FANCL-mediated Ubiquitylation in the Fanconi Anemia Pathway","volume":"14","author":"Cornwell","year":"2019","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.molcel.2021.04.023_bib22","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nm.4292","article-title":"HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures","volume":"23","author":"Davies","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.molcel.2021.04.023_bib23","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nrc3088","article-title":"DNA interstrand crosslink repair and cancer","volume":"11","author":"Deans","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.molcel.2021.04.023_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.dnarep.2018.02.003","article-title":"Inhibition of non-homologous end joining in Fanconi Anemia cells results in rescue of survival after interstrand crosslinks but sensitization to replication associated double-strand breaks","volume":"64","author":"Eccles","year":"2018","journal-title":"DNA Repair (Amst.)"},{"key":"10.1016\/j.molcel.2021.04.023_bib25","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1038\/s41467-020-15315-8","article-title":"Immunogenomic profiling determines responses to combined PARP and PD-1 inhibition in ovarian cancer","volume":"11","author":"F\u00e4rkkil\u00e4","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molcel.2021.04.023_bib26","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nature03445","article-title":"Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy","volume":"434","author":"Farmer","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.molcel.2021.04.023_bib27","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1107\/S2052252520009306","article-title":"Deep learning enables the atomic structure determination of the Fanconi Anemia core complex from cryoEM","volume":"7","author":"Farrell","year":"2020","journal-title":"IUCrJ"},{"key":"10.1016\/j.molcel.2021.04.023_bib28","doi-asserted-by":"crossref","first-page":"100589","DOI":"10.1016\/j.blre.2019.100589","article-title":"Genotype-phenotype associations in Fanconi anemia: A literature review","volume":"37","author":"Fiesco-Roa","year":"2019","journal-title":"Blood Rev."},{"key":"10.1016\/j.molcel.2021.04.023_bib29","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41523-019-0127-5","article-title":"The FANCM:p.Arg658\u2217 truncating variant is associated with risk of triple-negative breast cancer","volume":"5","author":"Figlioli","year":"2019","journal-title":"NPJ Breast Cancer"},{"key":"10.1016\/j.molcel.2021.04.023_bib30","series-title":"Fanconi Anemia: Guidelines for Diagnosis and Management","author":"Frohnmayer","year":"2014"},{"key":"10.1016\/j.molcel.2021.04.023_bib31","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1182\/blood.V95.4.1493.004k35_1493_1498","article-title":"The IVS4\u00a0+ 4 A to T mutation of the Fanconi anemia gene FANCC is not associated with a severe phenotype in Japanese patients","volume":"95","author":"Futaki","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.molcel.2021.04.023_bib32","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1101\/gad.17010011","article-title":"R-loop-mediated genomic instability is caused by impairment of replication fork progression","volume":"25","author":"Gan","year":"2011","journal-title":"Genes Dev."},{"key":"10.1016\/j.molcel.2021.04.023_bib33","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/nature11368","article-title":"Genotoxic consequences of endogenous aldehydes on mouse haematopoietic stem cell function","volume":"489","author":"Garaycoechea","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.molcel.2021.04.023_bib34","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/nature25154","article-title":"Alcohol and endogenous aldehydes damage chromosomes and mutate stem cells","volume":"553","author":"Garaycoechea","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.molcel.2021.04.023_bib35","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1097-2765(01)00173-3","article-title":"Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway","volume":"7","author":"Garcia-Higuera","year":"2001","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molcel.2021.04.023_bib36","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/s41586-018-0362-1","article-title":"53BP1 cooperation with the Rev7-Shieldin complex underpins DNA structure-specific NHEJ","volume":"560","author":"Ghezraoui","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.molcel.2021.04.023_bib37","first-page":"285","article-title":"Therapeutic applications of chemical warfare agents","volume":"5","author":"Gilman","year":"1946","journal-title":"Fed. Proc."},{"key":"10.1016\/j.molcel.2021.04.023_bib38","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.103.2675.409","article-title":"The Biological Actions and Therapeutic Applications of the B-Chloroethyl Amines and Sulfides","volume":"103","author":"Gilman","year":"1946","journal-title":"Science"},{"key":"10.1016\/j.molcel.2021.04.023_bib39","first-page":"4325105","article-title":"DNA Repair Deficiency in Breast Cancer: Opportunities for Immunotherapy","volume":"2019","author":"Gilmore","year":"2019","journal-title":"J.\u00a0Oncol."},{"key":"10.1016\/j.molcel.2021.04.023_bib40","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1001\/jama.1946.02870380008004","article-title":"Nitrogen mustard therapy; use of methyl-bis (beta-chloroethyl) amine hydrochloride and tris (beta-chloroethyl) amine hydrochloride for Hodgkin\u2019s disease, lymphosarcoma, leukemia and certain allied and miscellaneous disorders","volume":"132","author":"Goodman","year":"1946","journal-title":"J.\u00a0Am. Med. Assoc."},{"key":"10.1016\/j.molcel.2021.04.023_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mrrev.2018.11.001","article-title":"The molecular origins and pathophysiological consequences of micronuclei: New insights into an age-old problem","volume":"779","author":"Guo","year":"2019","journal-title":"Mutat. Res."},{"key":"10.1016\/j.molcel.2021.04.023_bib42","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.cell.2018.03.050","article-title":"DNA Repair Network Analysis Reveals Shieldin as a Key Regulator of NHEJ and PARP Inhibitor Sensitivity","volume":"173","author":"Gupta","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.molcel.2021.04.023_bib43","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/s41586-018-0670-5","article-title":"DYNLL1 binds to MRE11 to limit DNA end resection in BRCA1-deficient cells","volume":"563","author":"He","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.molcel.2021.04.023_bib44","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/ng.3342","article-title":"Loss-of-function variants in ATM confer risk of gastric cancer","volume":"47","author":"Helgason","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molcel.2021.04.023_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7554\/eLife.14740","article-title":"Small-molecule inhibitors identify the RAD52-ssDNA interaction as critical for recovery from replication stress and for survival of BRCA2 deficient cells","volume":"5","author":"Hengel","year":"2016","journal-title":"eLife"},{"key":"10.1016\/j.molcel.2021.04.023_bib46","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1182\/blood-2013-06-507962","article-title":"Variant ALDH2 is associated with accelerated progression of bone marrow failure in Japanese Fanconi anemia patients","volume":"122","author":"Hira","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.molcel.2021.04.023_bib47","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.str.2013.12.004","article-title":"Structure of the human FANCL RING-Ube2T complex reveals determinants of cognate E3-E2 selection","volume":"22","author":"Hodson","year":"2014","journal-title":"Structure"},{"key":"10.1016\/j.molcel.2021.04.023_bib48","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1093\/hmg\/ddi334","article-title":"Fancd2 functions in a double strand break repair pathway that is distinct from non-homologous end joining","volume":"14","author":"Houghtaling","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.molcel.2021.04.023_bib49","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41573-019-0046-z","article-title":"Synthetic lethality as an engine for cancer drug target discovery","volume":"19","author":"Huang","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.molcel.2021.04.023_bib50","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1476-4598-11-26","article-title":"Non-specific chemical inhibition of the Fanconi anemia pathway sensitizes cancer cells to cisplatin","volume":"11","author":"Jacquemont","year":"2012","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.molcel.2021.04.023_bib51","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1182\/blood.2019003249","article-title":"Association of clinical severity with FANCB variant type in Fanconi anemia","volume":"135","author":"Jung","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.molcel.2021.04.023_bib52","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1016\/j.celrep.2016.05.031","article-title":"FANCD2 Maintains Fork Stability in BRCA1\/2-Deficient Tumors and Promotes Alternative End-Joining DNA Repair","volume":"15","author":"Kais","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.molcel.2021.04.023_bib53","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1172\/JCI31245","article-title":"Fanconi anemia pathway-deficient tumor cells are hypersensitive to inhibition of ataxia telangiectasia mutated","volume":"117","author":"Kennedy","year":"2007","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.molcel.2021.04.023_bib54","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1182\/blood-2012-07-441212","article-title":"Regulation of multiple DNA repair pathways by the Fanconi anemia protein SLX4","volume":"121","author":"Kim","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.molcel.2021.04.023_bib55","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/humu.23366","article-title":"A comprehensive approach to identification of pathogenic FANCA variants in Fanconi anemia patients and their families","volume":"39","author":"Kimble","year":"2018","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.molcel.2021.04.023_bib56","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1126\/science.1182372","article-title":"The Fanconi Anemia Pathway Promotes Replication-Dependent DNA Interstrand Cross-Link Repair","volume":"2","author":"Knipscheer","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.molcel.2021.04.023_bib57","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nature11863","article-title":"Fanconi anaemia and the repair of Watson and Crick DNA crosslinks","volume":"493","author":"Kottemann","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.molcel.2021.04.023_bib58","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1182\/blood-2002-07-2170","article-title":"A 20-year perspective on the International Fanconi Anemia Registry (IFAR)","volume":"101","author":"Kutler","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.molcel.2021.04.023_bib59","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/ijc.24039","article-title":"A novel cell-free screen identifies a potent inhibitor of the Fanconi anemia pathway","volume":"124","author":"Landais","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.molcel.2021.04.023_bib60","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/1476-4598-8-133","article-title":"Monoketone analogs of curcumin, a new class of Fanconi anemia pathway inhibitors","volume":"8","author":"Landais","year":"2009","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.molcel.2021.04.023_bib61","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/nature10192","article-title":"Fancd2 counteracts the toxic effects of naturally produced aldehydes in mice","volume":"475","author":"Langevin","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.molcel.2021.04.023_bib62","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nchembio.1455","article-title":"A selective USP1-UAF1 inhibitor links deubiquitination to DNA damage responses","volume":"10","author":"Liang","year":"2014","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.molcel.2021.04.023_bib63","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.molcel.2018.10.045","article-title":"USP1 Is Required for Replication Fork Protection in BRCA1-Deficient Tumors","volume":"72","author":"Lim","year":"2018","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molcel.2021.04.023_bib64","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1158\/1078-0432.CCR-14-2616","article-title":"Acquisition of relative interstrand crosslinker resistance and PARP inhibitor sensitivity in Fanconi anemia head and neck cancers","volume":"21","author":"Lombardi","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.molcel.2021.04.023_bib65","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1126\/science.aam7344","article-title":"PARP inhibitors: Synthetic lethality in the clinic","volume":"355","author":"Lord","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.molcel.2021.04.023_bib66","doi-asserted-by":"crossref","first-page":"e1004471","DOI":"10.1371\/journal.pgen.1004471","article-title":"Hypersensitivity of primordial germ cells to compromised replication-associated DNA repair involves ATM-p53-p21 signaling","volume":"10","author":"Luo","year":"2014","journal-title":"PLoS Genet."},{"key":"10.1016\/j.molcel.2021.04.023_bib67","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.molcel.2006.06.024","article-title":"UBE2T is the E2 in the Fanconi anemia pathway and undergoes negative autoregulation","volume":"23","author":"Machida","year":"2006","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molcel.2021.04.023_bib68","doi-asserted-by":"crossref","first-page":"8109","DOI":"10.1158\/0008-5472.CAN-06-0140","article-title":"Deficiency in the repair of DNA damage by homologous recombination and sensitivity to poly(ADP-ribose) polymerase inhibition","volume":"66","author":"McCabe","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.molcel.2021.04.023_bib69","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/ng1241","article-title":"A novel ubiquitin ligase is deficient in Fanconi anemia","volume":"35","author":"Meetei","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molcel.2021.04.023_bib70","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1158\/1541-7786.MCR-14-0240","article-title":"A synthetic lethal screen reveals enhanced sensitivity to ATR inhibitor treatment in mantle cell lymphoma with ATM loss-of-function","volume":"13","author":"Menezes","year":"2015","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.molcel.2021.04.023_bib71","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/nsmb.3252","article-title":"FANCD2 limits replication stress and genome instability in cells lacking BRCA2","volume":"23","author":"Michl","year":"2016","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.molcel.2021.04.023_bib122","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1038\/s41467-017-01439-x","article-title":"Parallel genome-wide screens identify synthetic viable interactions between the BLM helicase complex and Fanconi anemia","volume":"8","author":"Moder","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molcel.2021.04.023_bib72","doi-asserted-by":"crossref","first-page":"4093","DOI":"10.1021\/acs.jmedchem.7b00147","article-title":"Allosteric targeting of the Fanconi anemia ubiquitin-conjugating enzyme Ube2T by fragment screening","volume":"60","author":"Morreale","year":"2017","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.molcel.2021.04.023_bib73","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1073\/pnas.0407796102","article-title":"Human Fanconi anemia monoubiquitination pathway promotes homologous DNA repair","volume":"102","author":"Nakanishi","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.molcel.2021.04.023_bib74","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.molcel.2005.01.008","article-title":"The deubiquitinating enzyme USP1 regulates the Fanconi anemia pathway","volume":"17","author":"Nijman","year":"2005","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molcel.2021.04.023_bib75","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1146\/annurev-cancerbio-030617-050422","article-title":"The Fanconi Anemia Pathway in Cancer","volume":"3","author":"Niraj","year":"2019","journal-title":"Annu. Rev. Cancer Biol."},{"key":"10.1016\/j.molcel.2021.04.023_bib76","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/s41586-018-0340-7","article-title":"The shieldin complex mediates 53BP1-dependent DNA repair","volume":"560","author":"Noordermeer","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.molcel.2021.04.023_bib77","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1126\/science.1192277","article-title":"Ku70 Corrupts DNA Repair in the Absence of the Fanconi Anemia Pathway","volume":"329","author":"Pace","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.molcel.2021.04.023_bib78","doi-asserted-by":"crossref","first-page":"djw199","DOI":"10.1093\/jnci\/djw199","article-title":"Activation of STING-Dependent Innate Immune Signaling By S-Phase-Specific DNA Damage in Breast Cancer","volume":"109","author":"Parkes","year":"2016","journal-title":"J.\u00a0Natl. Cancer Inst."},{"key":"10.1016\/j.molcel.2021.04.023_bib79","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/nrc3891","article-title":"Therapeutic opportunities within the DNA damage response","volume":"15","author":"Pearl","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.molcel.2021.04.023_bib80","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1038\/s41467-018-03917-2","article-title":"Genome-wide and high-density CRISPR-Cas9 screens identify point mutations in PARP1 causing PARP inhibitor resistance","volume":"9","author":"Pettitt","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molcel.2021.04.023_bib81","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3324\/haematol.13592","article-title":"Diagnosis of Fanconi anemia in patients with bone marrow failure","volume":"94","author":"Pinto","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.molcel.2021.04.023_bib82","doi-asserted-by":"crossref","first-page":"7003","DOI":"10.1074\/jbc.M113.533976","article-title":"The carboxyl terminus of FANCE recruits FANCD2 to the Fanconi Anemia (FA) E3 ligase complex to promote the FA DNA repair pathway","volume":"289","author":"Polito","year":"2014","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.molcel.2021.04.023_bib83","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.molcel.2014.05.001","article-title":"The genetic and biochemical basis of FANCD2 monoubiquitination","volume":"54","author":"Rajendra","year":"2014","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molcel.2021.04.023_bib84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2019.12.008","article-title":"Chromosome fragility in the buccal epithelium in patients with Fanconi anemia","volume":"472","author":"Ram\u00edrez","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.molcel.2021.04.023_bib85","first-page":"3546","article-title":"Proteomic analysis reveals a FANCA-modulated neddylation pathway involved in CXCR5 membrane targeting and cell mobility","volume":"127","author":"Renaudin","year":"2014","journal-title":"J.\u00a0Cell Sci."},{"key":"10.1016\/j.molcel.2021.04.023_bib86","doi-asserted-by":"crossref","first-page":"e50133","DOI":"10.15252\/embr.202050133","article-title":"Differential functions of FANCI and FANCD2 ubiquitination stabilize ID2 complex on DNA","volume":"21","author":"Rennie","year":"2020","journal-title":"EMBO Rep."},{"key":"10.1016\/j.molcel.2021.04.023_bib87","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/ng1837","article-title":"ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles","volume":"38","author":"Renwick","year":"2006","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molcel.2021.04.023_bib88","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1038\/s41588-018-0174-0","article-title":"CRISPR-Cas9 genome editing in human cells occurs via the Fanconi Anemia pathway","volume":"50","author":"Richardson","year":"2018","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molcel.2021.04.023_bib89","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1038\/ncb3626","article-title":"EZH2 promotes degradation of stalled replication forks by recruiting MUS81 through histone H3 trimethylation","volume":"19","author":"Rondinelli","year":"2017","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.molcel.2021.04.023_bib90","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/nature13660","article-title":"Synergistic blockade of mitotic exit by two chemical inhibitors of the APC\/C","volume":"514","author":"Sackton","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.molcel.2021.04.023_bib91","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.cell.2011.03.041","article-title":"Double-strand break repair-independent role for BRCA2 in blocking stalled replication fork degradation by MRE11","volume":"145","author":"Schlacher","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.molcel.2021.04.023_bib92","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ccr.2012.05.015","article-title":"A distinct replication fork protection pathway connects Fanconi anemia tumor suppressors to RAD51-BRCA1\/2","volume":"22","author":"Schlacher","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.molcel.2021.04.023_bib93","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.molcel.2015.09.012","article-title":"The Fanconi Anemia Pathway Maintains Genome Stability by Coordinating Replication and Transcription","volume":"60","author":"Schwab","year":"2015","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molcel.2021.04.023_bib94","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1182\/blood.V85.8.2233.bloodjournal8582233","article-title":"Comparative evaluation of diepoxybutane sensitivity and cell cycle blockage in the diagnosis of Fanconi anemia","volume":"85","author":"Seyschab","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.molcel.2021.04.023_bib95","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/s41586-019-1703-4","article-title":"Structure of the Fanconi anaemia monoubiquitin ligase complex","volume":"575","author":"Shakeel","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.molcel.2021.04.023_bib96","doi-asserted-by":"crossref","first-page":"7959","DOI":"10.1038\/s41598-020-64868-7","article-title":"Methodology for the identification of small molecule inhibitors of the Fanconi Anaemia ubiquitin E3 ligase complex","volume":"10","author":"Sharp","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.molcel.2021.04.023_bib97","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nrm3546","article-title":"The ATM protein kinase: Regulating the cellular response to genotoxic stress, and more","volume":"14","author":"Shiloh","year":"2013","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.molcel.2021.04.023_bib98","doi-asserted-by":"crossref","first-page":"4649","DOI":"10.1182\/blood-2002-05-1399","article-title":"A novel diagnostic screen for defects in the Fanconi anemia pathway","volume":"100","author":"Shimamura","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.molcel.2021.04.023_bib99","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.cell.2007.03.009","article-title":"Identification of the FANCI protein, a monoubiquitinated FANCD2 paralog required for DNA repair","volume":"129","author":"Smogorzewska","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.molcel.2021.04.023_bib100","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.dnarep.2014.12.003","article-title":"DNA helicases FANCM and DDX11 are determinants of PARP inhibitor sensitivity","volume":"26","author":"Stoepker","year":"2015","journal-title":"DNA Repair (Amst.)"},{"key":"10.1016\/j.molcel.2021.04.023_bib101","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1021\/ar700246x","article-title":"Interstrand DNA cross-links induced by \u03b1,\u03b2-unsaturated aldehydes derived from lipid peroxidation and environmental sources","volume":"41","author":"Stone","year":"2008","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.molcel.2021.04.023_bib102","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.chembiol.2011.12.013","article-title":"Structural biology and drug discovery of difficult targets: the limits of ligandability","volume":"19","author":"Surade","year":"2012","journal-title":"Chem. Biol."},{"key":"10.1016\/j.molcel.2021.04.023_bib103","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.celrep.2016.11.013","article-title":"The FA Core Complex Contains a Homo-dimeric Catalytic Module for the Symmetric Mono-ubiquitination of FANCI-FANCD2","volume":"18","author":"Swuec","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.molcel.2021.04.023_bib104","doi-asserted-by":"crossref","first-page":"e54128","DOI":"10.7554\/eLife.54128","article-title":"Monoubiquitination by the human Fanconi anemia core complex clamps FANCI:FANCD2 on DNA in filamentous arrays","volume":"9","author":"Tan","year":"2020","journal-title":"eLife"},{"key":"10.1016\/j.molcel.2021.04.023_bib105","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1182\/blood-2002-01-0278","article-title":"S-phase-specific interaction of the Fanconi anemia protein, FANCD2, with BRCA1 and RAD51","volume":"100","author":"Taniguchi","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.molcel.2021.04.023_bib106","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1200\/JCO.2017.75.7740","article-title":"Alterations in DNA damage response and repair genes as potential marker of clinical benefit from PD-1\/PD-L1 blockade in advanced urothelial cancers","volume":"36","author":"Teo","year":"2018","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.molcel.2021.04.023_bib107","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1080\/15384101.2020.1810394","article-title":"Suppression of non-homologous end joining does not rescue DNA repair defects in Fanconi anemia patient cells","volume":"19","author":"Thongthip","year":"2020","journal-title":"Cell Cycle"},{"key":"10.1016\/j.molcel.2021.04.023_bib108","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s13045-017-0500-5","article-title":"MDM2\/X inhibitors under clinical evaluation: perspectives for the management of hematological malignancies and pediatric cancer","volume":"10","author":"Tisato","year":"2017","journal-title":"J.\u00a0Hematol. Oncol."},{"key":"10.1016\/j.molcel.2021.04.023_bib109","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.tig.2018.12.007","article-title":"The Fanconi Anemia Pathway and Fertility","volume":"35","author":"Tsui","year":"2019","journal-title":"Trends Genet."},{"key":"10.1016\/j.molcel.2021.04.023_bib110","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.molcel.2016.11.005","article-title":"Mechanism of Ubiquitination and Deubiquitination in the Fanconi Anemia Pathway","volume":"65","author":"van Twest","year":"2017","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molcel.2021.04.023_bib111","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1126\/science.1092472","article-title":"In\u00a0Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2","volume":"303","author":"Vassilev","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.molcel.2021.04.023_bib121","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1038\/s41467-018-04649-z","article-title":"Map of synthetic rescue interactions for the Fanconi anemia DNA repair pathway identifies USP48","volume":"9","author":"Velimezi","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molcel.2021.04.023_bib112","doi-asserted-by":"crossref","first-page":"4034","DOI":"10.1182\/blood.V86.11.4034.bloodjournal86114034","article-title":"Carrier frequency of the IVS4\u00a0+ 4 A\u2192T mutation of the Fanconi anemia gene FAC in the Ashkenazi Jewish population","volume":"86","author":"Verlander","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.molcel.2021.04.023_bib113","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jnci\/djv437","article-title":"Veliparib alone or in combination with mitomycin C in patients with solid tumors with functional deficiency in homologous recombination repair","volume":"108","author":"Villalona-Calero","year":"2016","journal-title":"J.\u00a0Natl. Cancer Inst."},{"key":"10.1016\/j.molcel.2021.04.023_bib114","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/s41586-020-2110-6","article-title":"DNA clamp function of the monoubiquitinated Fanconi anaemia ID complex","volume":"580","author":"Wang","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.molcel.2021.04.023_bib115","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/s41594-021-00568-8","article-title":"Structure of the FA core ubiquitin ligase closing the ID clamp on DNA","volume":"28","author":"Wang","year":"2021","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.molcel.2021.04.023_bib116","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1038\/s41467-020-15845-1","article-title":"Timed inhibition of CDC7 increases CRISPR-Cas9 mediated templated repair","volume":"11","author":"Wienert","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molcel.2021.04.023_bib117","doi-asserted-by":"crossref","first-page":"E292","DOI":"10.1002\/hed.23155","article-title":"Squamous cell carcinoma of the oral tongue in a patient with Fanconi anemia treated with radiotherapy and concurrent cetuximab: a case report and review of the literature","volume":"35","author":"Wong","year":"2013","journal-title":"Head Neck"},{"key":"10.1016\/j.molcel.2021.04.023_bib118","doi-asserted-by":"crossref","first-page":"55352","DOI":"10.18632\/oncotarget.10536","article-title":"Ranking novel cancer driving synthetic lethal gene pairs using TCGA data","volume":"7","author":"Ye","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.molcel.2021.04.023_bib119","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/nsmb.1605","article-title":"E2 interaction and dimerization in the crystal structure of TRAF6","volume":"16","author":"Yin","year":"2009","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.molcel.2021.04.023_bib120","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.ccr.2010.08.010","article-title":"Pharmacologic inhibition of the anaphase-promoting complex induces a spindle checkpoint-dependent mitotic arrest in the absence of spindle damage","volume":"18","author":"Zeng","year":"2010","journal-title":"Cancer Cell"}],"container-title":["Molecular Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1097276521003282?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1097276521003282?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T12:51:43Z","timestamp":1778590303000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1097276521003282"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":122,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S1097276521003282"],"URL":"https:\/\/doi.org\/10.1016\/j.molcel.2021.04.023","relation":{},"ISSN":["1097-2765"],"issn-type":[{"value":"1097-2765","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Fanconi anemia ubiquitin E3 ligase complex as an anti-cancer target","name":"articletitle","label":"Article Title"},{"value":"Molecular Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molcel.2021.04.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}